DK1000086T3 - Parenterale alatrofloxacinpræparater - Google Patents

Parenterale alatrofloxacinpræparater

Info

Publication number
DK1000086T3
DK1000086T3 DK98932444T DK98932444T DK1000086T3 DK 1000086 T3 DK1000086 T3 DK 1000086T3 DK 98932444 T DK98932444 T DK 98932444T DK 98932444 T DK98932444 T DK 98932444T DK 1000086 T3 DK1000086 T3 DK 1000086T3
Authority
DK
Denmark
Prior art keywords
alatrofloxacin
parenteral
preparations
parenteral alatrofloxacin
alatrofloxacin preparations
Prior art date
Application number
DK98932444T
Other languages
Danish (da)
English (en)
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1000086T3 publication Critical patent/DK1000086T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98932444T 1997-08-01 1998-07-23 Parenterale alatrofloxacinpræparater DK1000086T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01
PCT/IB1998/001122 WO1999006430A1 (en) 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions

Publications (1)

Publication Number Publication Date
DK1000086T3 true DK1000086T3 (da) 2004-05-17

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98932444T DK1000086T3 (da) 1997-08-01 1998-07-23 Parenterale alatrofloxacinpræparater

Country Status (40)

Country Link
US (1) US6194429B1 (sh)
EP (1) EP1000086B1 (sh)
JP (1) JP3463928B2 (sh)
KR (1) KR20010022495A (sh)
CN (1) CN1265671A (sh)
AP (1) AP1031A (sh)
AR (1) AR015417A1 (sh)
AT (1) ATE259827T1 (sh)
AU (1) AU734863B2 (sh)
BG (1) BG104105A (sh)
BR (1) BR9811580A (sh)
CA (1) CA2296466C (sh)
CO (1) CO4970688A1 (sh)
DE (1) DE69821767T2 (sh)
DK (1) DK1000086T3 (sh)
DZ (1) DZ2576A1 (sh)
EA (1) EA002120B1 (sh)
ES (1) ES2214716T3 (sh)
GT (1) GT199800112A (sh)
HN (1) HN1998000106A (sh)
HR (1) HRP980417B1 (sh)
HU (1) HUP0004793A3 (sh)
ID (1) ID24374A (sh)
IL (1) IL134156A0 (sh)
IS (1) IS5339A (sh)
MA (1) MA24626A1 (sh)
NO (1) NO20000485L (sh)
NZ (1) NZ502249A (sh)
OA (1) OA11281A (sh)
PA (1) PA8456701A1 (sh)
PE (1) PE103799A1 (sh)
PL (1) PL338477A1 (sh)
PT (1) PT1000086E (sh)
SK (1) SK1012000A3 (sh)
TN (1) TNSN98146A1 (sh)
TW (1) TW538043B (sh)
UY (1) UY25113A1 (sh)
WO (1) WO1999006430A1 (sh)
YU (1) YU2500A (sh)
ZA (1) ZA986874B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Fabi阻害剤
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
ATE420640T1 (de) * 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
US7790709B2 (en) * 2002-12-06 2010-09-07 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
DK1828167T3 (da) 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
AU2015249222A1 (en) * 2014-04-25 2016-11-17 Naurex, Inc. Stable compositions of neuroactive peptides
PT3419628T (pt) 2016-02-26 2021-01-05 Debiopharm Int Sa Medicamento para o tratamento de infeções do pé diabético
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
EP4146664A2 (en) 2020-05-01 2023-03-15 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
WO1995019361A1 (en) 1994-01-18 1995-07-20 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
EP0789697B1 (en) 1995-06-06 1998-06-17 Pfizer Inc. CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
DE69622715T2 (de) * 1995-06-15 2002-11-14 Pfizer Inc., New York Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin-carbonsäure
IL122652A (en) 1995-08-29 2000-01-31 Pfizer Polymorphs of the pro drug 6-n-(l-ala-l-ala)- trovafloxacin their preparation and pharmaceutical compositions containing them
WO1997007800A1 (en) 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
BG104105A (bg) 2000-08-31
PA8456701A1 (es) 2000-05-24
HUP0004793A3 (en) 2001-10-29
CA2296466A1 (en) 1999-02-11
AP9801310A0 (en) 1998-09-30
HN1998000106A (es) 1999-01-08
UY25113A1 (es) 2000-12-29
NO20000485D0 (no) 2000-01-31
HRP980417B1 (en) 2002-10-31
WO1999006430A1 (en) 1999-02-11
ID24374A (id) 2000-07-13
PE103799A1 (es) 1999-10-25
MA24626A1 (fr) 1999-04-01
JP3463928B2 (ja) 2003-11-05
IS5339A (is) 2000-01-14
AP1031A (en) 2001-12-21
ATE259827T1 (de) 2004-03-15
HRP980417A2 (en) 1999-08-31
CO4970688A1 (es) 2000-11-07
BR9811580A (pt) 2000-08-22
AU8236898A (en) 1999-02-22
SK1012000A3 (en) 2000-09-12
PT1000086E (pt) 2004-05-31
HUP0004793A2 (hu) 2001-04-28
ZA986874B (en) 2000-01-31
AR015417A1 (es) 2001-05-02
DE69821767T2 (de) 2005-01-13
AU734863B2 (en) 2001-06-21
IL134156A0 (en) 2001-04-30
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
GT199800112A (es) 2000-01-15
EP1000086B1 (en) 2004-02-18
EA200000086A1 (ru) 2000-08-28
OA11281A (en) 2002-11-19
YU2500A (sh) 2002-09-19
EP1000086A1 (en) 2000-05-17
TNSN98146A1 (fr) 2005-03-15
US6194429B1 (en) 2001-02-27
KR20010022495A (ko) 2001-03-15
CN1265671A (zh) 2000-09-06
DE69821767D1 (de) 2004-03-25
EA002120B1 (ru) 2001-12-24
JP2001512133A (ja) 2001-08-21
NZ502249A (en) 2001-11-30
NO20000485L (no) 2000-03-27
DZ2576A1 (fr) 2003-02-22
ES2214716T3 (es) 2004-09-16
CA2296466C (en) 2003-04-15

Similar Documents

Publication Publication Date Title
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
NO972480L (no) Interferonkonjugater
DE69827307D1 (de) Turbolader
NO982686L (no) R°rledningsplugg
NO980389D0 (no) Telefonsystem
DE69810721D1 (de) Taktsteuerung
DE69814990D1 (de) Einspritzventil
DK1000086T3 (da) Parenterale alatrofloxacinpræparater
DE59707298D1 (de) Desodorierende zubereitungen
NO20002555D0 (no) Skjøt
NO974175L (no) B°lgekraftverk
DK0862850T3 (da) Mejetærsker
PT1015447E (pt) Derivado piperidinilmetiloxazolidinona
NO974892L (no) Ventilasjonsr°r
DE69811185D1 (de) Ordner
FR2770103B1 (fr) Bigoudi perfectionne
FR2769951B1 (fr) Turbocompresseur
FI972138A0 (fi) Returtraog i bestrykningsanordning
KR980001295U (ko) 개량 도장
FIU970229U0 (fi) Asiapaperikansio
KR970050762U (ko) 책상
NO975385L (no) D°rstopper
FIU970351U0 (fi) Kirjatuki
KR980001299U (ko) 노트책
SE9703419D0 (sv) Arrangemang